1. Home
  2. CAN vs CERS Comparison

CAN vs CERS Comparison

Compare CAN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • CERS
  • Stock Information
  • Founded
  • CAN 2013
  • CERS 1991
  • Country
  • CAN Singapore
  • CERS United States
  • Employees
  • CAN N/A
  • CERS N/A
  • Industry
  • CAN Semiconductors
  • CERS EDP Services
  • Sector
  • CAN Technology
  • CERS Technology
  • Exchange
  • CAN Nasdaq
  • CERS Nasdaq
  • Market Cap
  • CAN 330.5M
  • CERS 265.7M
  • IPO Year
  • CAN 2019
  • CERS 1997
  • Fundamental
  • Price
  • CAN $0.66
  • CERS $1.27
  • Analyst Decision
  • CAN Strong Buy
  • CERS Strong Buy
  • Analyst Count
  • CAN 6
  • CERS 2
  • Target Price
  • CAN $2.67
  • CERS $3.50
  • AVG Volume (30 Days)
  • CAN 58.1M
  • CERS 882.9K
  • Earning Date
  • CAN 08-14-2025
  • CERS 08-05-2025
  • Dividend Yield
  • CAN N/A
  • CERS N/A
  • EPS Growth
  • CAN N/A
  • CERS N/A
  • EPS
  • CAN N/A
  • CERS N/A
  • Revenue
  • CAN $317,009,000.00
  • CERS $185,144,000.00
  • Revenue This Year
  • CAN $115.67
  • CERS $24.95
  • Revenue Next Year
  • CAN $63.75
  • CERS $11.88
  • P/E Ratio
  • CAN N/A
  • CERS N/A
  • Revenue Growth
  • CAN 65.68
  • CERS 13.06
  • 52 Week Low
  • CAN $0.53
  • CERS $1.12
  • 52 Week High
  • CAN $3.27
  • CERS $2.54
  • Technical
  • Relative Strength Index (RSI)
  • CAN 42.69
  • CERS 39.38
  • Support Level
  • CAN $0.65
  • CERS $1.34
  • Resistance Level
  • CAN $0.71
  • CERS $1.41
  • Average True Range (ATR)
  • CAN 0.09
  • CERS 0.07
  • MACD
  • CAN -0.03
  • CERS -0.02
  • Stochastic Oscillator
  • CAN 7.64
  • CERS 6.67

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: